Form 4: Teladoc Health Executive Trades TDOC Shares

Teladoc Health's Chief Accounting Officer, Joseph Ronald Catapano, reported transactions involving restricted stock units and common stock sales.

Summary

• Joseph Ronald Catapano, Chief Accounting Officer at Teladoc Health, Inc., engaged in stock transactions on April 1st and 2nd, 2026.
• On April 1st, 2026, 2,083 restricted stock units (RSUs) were acquired, converting into 2,083 shares of common stock.
• These RSUs were part of a grant on October 1st, 2024, with a vesting schedule of one-third on the first anniversary and the remainder in eight equal quarterly installments.
• On April 2nd, 2026, 675 shares of common stock were sold at a price of $5.114 per share.
• This sale was to cover tax withholding obligations related to the vesting of RSUs.
• Following these transactions, Mr. Catapano beneficially owns 10,249 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine insider transactions related to equity compensation rather than significant strategic or financial performance indicators.

Positives

• Vesting of restricted stock units indicates continued equity compensation for the Chief Accounting Officer.
• The acquisition of 2,083 shares through RSU conversion shows an increase in direct share ownership.

Negatives

• Sale of 675 shares to cover tax withholding obligations suggests a need to liquidate equity to meet tax liabilities.

Risks

• The sale of shares to cover taxes could be interpreted as a need for immediate liquidity by the executive, though it is a standard practice for RSU vesting.
• The relatively low sale price of $5.114 per share might reflect current market conditions for TDOC.

Future Outlook

The filing does not contain forward-looking statements or guidance. It reports on past transactions.

Industry Context

StockSavvy.ai notes that insider transactions, such as those reported by Teladoc Health's Chief Accounting Officer, are common for executives managing equity compensation. The sale to cover taxes is a routine event tied to RSU vesting schedules and does not necessarily indicate a negative view of the company's prospects, though the price at which shares are sold can provide some market context.

Stakeholder Impact

• Shareholders: The sale of shares by an executive to cover taxes is a common occurrence and typically has a minimal direct impact on the stock price, though it can be monitored as part of overall insider activity.
• Employees: The filing highlights the company's use of equity compensation (RSUs) as part of its employee incentive structure.
• Management: Demonstrates adherence to reporting requirements for beneficial ownership changes.

Next Steps

• Continued vesting of remaining restricted stock units according to the schedule outlined in the grant.
• Potential future sales by the reporting person to cover tax obligations or for personal liquidity, depending on market conditions and personal financial needs.

Key Dates

Keywords

Teladoc Health, TDOC, Form 4, Insider Trading, Stock Transaction, Restricted Stock Units, RSU Vesting, Chief Accounting Officer, Joseph Ronald Catapano, Tax Withholding